SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.850-2.6%Nov 7 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: HardToFind who wrote (12638)2/3/2020 6:13:48 PM
From: HardToFind  Read Replies (1) of 12871
 
Sold my entire position today at $12.

Although I believe these things, they alone don't matter:
  1. NNVC can get a good herpes drug past IND filing
  2. NNVC could quickly develop a new Coronavirus drug
How could I be wrong to sell now?: (these would make the stock rise, which would likely present a better exit).
  1. Somebody could believe Diwan and give them lots of money to develop a Coronavirus drug.
  2. Diwan could do an equity offering at a higher share price, allowing clinical testing of HerpeCide.
  3. These drugs could become so profitable that even the company makes enough money to sustain itself and build a business (although highly unlikely).
The stock price is fighting an uphill battle because:
  1. Management appears to be corrupt and double-dealing
  2. The royalty agreement appears to be egregiously unfair
  3. Management has not demonstrated sufficient business competence, only technical competence
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News